These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New and emerging therapies for pulmonary complications of cystic fibrosis. Tonelli MR; Aitken ML Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent. Chmiel JF; Konstan MW Treat Respir Med; 2005; 4(4):255-73. PubMed ID: 16086599 [TBL] [Abstract][Full Text] [Related]
8. The role of inhaled corticosteroids in the management of cystic fibrosis. Ross KR; Chmiel JF; Konstan MW Paediatr Drugs; 2009; 11(2):101-13. PubMed ID: 19301932 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus in early cystic fibrosis lung disease. Wong JK; Ranganathan SC; Hart E; Pediatr Pulmonol; 2013 Dec; 48(12):1151-9. PubMed ID: 23970476 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future. Oermann CM Curr Opin Investig Drugs; 2001 Jul; 2(7):900-6. PubMed ID: 11757788 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Konstan MW; Davis PB Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152 [TBL] [Abstract][Full Text] [Related]
14. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes. Oermann CM; Sockrider MM; Konstan MW Chest; 1999 Apr; 115(4):1053-8. PubMed ID: 10208207 [TBL] [Abstract][Full Text] [Related]
15. Early airway infection, inflammation, and lung function in cystic fibrosis. Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K; Wainwright C Arch Dis Child; 2002 Oct; 87(4):306-11. PubMed ID: 12244003 [TBL] [Abstract][Full Text] [Related]
16. Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages. Gillan JL; Davidson DJ; Gray RD Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303535 [TBL] [Abstract][Full Text] [Related]
17. Treating the Airway Consequences of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction. Toprak D; Davis C; Rosenfeld M Semin Respir Crit Care Med; 2019 Dec; 40(6):751-761. PubMed ID: 31659732 [TBL] [Abstract][Full Text] [Related]
20. The role of inflammation in the pathophysiology of CF lung disease. Chmiel JF; Berger M; Konstan MW Clin Rev Allergy Immunol; 2002 Aug; 23(1):5-27. PubMed ID: 12162106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]